Ultrasound and surface acoustic wave powered transdermal drug delivery: Mechanisms, technological advances, and future perspectives
Biomedical Instrumentation · 2026-11 · 100074
DOI: 10.1016/j.bmi.2026.100074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Instrumentation, 2026-11. Verfasst von Jikai Zhang und 9 weiteren Autor:innen. Die Arbeit nennt 300 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Transdermal drug delivery (TDD) offers a unique non-invasive route for therapeutic administration, but its widespread application is constrained by the barrier function of the stratum corneum (SC) of the skin layer. Ultrasound and surface acoustic wave (SAW) technologies have emerged as promising physical approaches for enhancing skin permeability and facilitating transdermal transport of therapeutic agents. Acoustic stimulation generates a range of biophysical effects, including acoustic radiation, cavitation, acoustic streaming, and localised thermal modulation, which collectively perturb the structural integrity of the SC layer and effectively promote molecular transport across the skin. This paper reviews fundamental ultrasound and acoustic TDD mechanisms and recent advances in biomedical acoustics, microfabrication, materials engineering technologies, and diverse acoustic-mediated delivery platforms, which include focused ultrasound systems, microbubble-assisted sonoporation, ultrasound-responsive nanocarriers, microneedle (MN)–acoustic hybrid systems, and SAW enhancing technologies. Despite significant progress, several challenges are identified, including the precise control of acoustic bioeffects, efficient delivery of macromolecules or therapeutic biomolecules, and establishment of standardised treatment parameters and safety guidelines. Future innovations are highlighted in the fields of integration of multimodal delivery strategies, wearable acoustic devices, and intelligent feedback-controlled systems, which can improve the efficacy, safety, and clinical translatability of ultrasound- and SAW-mediated TDD.
Zitieren
APA
Zhang, J., Zhang, X., Han, Z., Wang, Z., Yuan, Z., Tao, R., Fu, C., Luo, J., Yang, X., & Fu, Y. (2026). Ultrasound and surface acoustic wave powered transdermal drug delivery: Mechanisms, technological advances, and future perspectives. Biomedical Instrumentation, 100074. https://doi.org/10.1016/j.bmi.2026.100074
Vancouver
Zhang J, Zhang X, Han Z, Wang Z, Yuan Z, Tao R, et al. Ultrasound and surface acoustic wave powered transdermal drug delivery: Mechanisms, technological advances, and future perspectives. Biomedical Instrumentation. 2026:100074. doi:10.1016/j.bmi.2026.100074
BibTeX
@article{Zhang2026,
author = {Zhang, Jikai and Zhang, Xiaoyan and Han, Zhushan and Wang, Zenan and Yuan, Zhishan and Tao, Ran and Fu, Chen and Luo, Jingting and Yang, Xin and Fu, Yongqing},
title = {Ultrasound and surface acoustic wave powered transdermal drug delivery: Mechanisms, technological advances, and future perspectives},
journal = {Biomedical Instrumentation},
year = {2026},
pages = {100074},
doi = {10.1016/j.bmi.2026.100074}
}
EUVIMED